ClearPoint Neuro (CLPT) Invested Capital (2011 - 2026)

ClearPoint Neuro has disclosed Invested Capital across 16 years of filings, most recently posting $18.8 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $18.8 million, down 5.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $18.8 million (down 5.73% YoY), and the FY2025 annual result was $28.0 million, up 10.36% from the prior year.
• Invested Capital came in at $18.8 million for Q1 2026 at ClearPoint Neuro, down from $28.0 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $55.6 million in Q1 2022 to a low of $15.9 million in Q3 2025.
• The 5-year median for Invested Capital is $34.0 million (2023), against an average of $34.9 million.
• Across the five-year window, Invested Capital grew 26.37% in 2022 and tumbled 55.13% in 2025, its largest moves.
• ClearPoint Neuro's Invested Capital stood at $46.8 million in 2022, then sank by 33.36% to $31.2 million in 2023, then dropped by 18.55% to $25.4 million in 2024, then grew by 10.36% to $28.0 million in 2025, then slumped by 32.76% to $18.8 million in 2026.
• The last three Invested Capital figures came in at $18.8 million (Q1 2026), $28.0 million (Q4 2025), and $15.9 million (Q3 2025), per Business Quant data.